CCR5 inhibition may decrease obesity-induced adipose tissue inflammation and shift to M2 population via recruitment and polarization to anti-inflammatory phenotype; protects against diabetes in obese mice. Here, CCR5 is linked to obesity due to melanocortin 4 receptor deficiency.